Apr 10, 2020
Lilly Begins Clinical Testing of Therapies for COVID-19
Jan 31, 2020
Immunitor unveils breakthrough immunotherapy to treat tuberculosis in as short as one month
Aug 23, 2019
Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis
Jul 23, 2019
Global Latent Tuberculosis Infection Testing Market 2019-2023: Rising Prevalence of HIV and Increasing Government Initiatives to Drive Market Growth
Feb 04, 2019
Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
Oct 21, 2018
ACR 2018: Lilly Shares Updated Safety Analysis of OLUMIANT® (baricitinib) in Patients with Moderately-to-Severely Active Rheumatoid Arthritis
Oct 01, 2018
IAVI Acquires Aeras TB Vaccine Clinical Programs and Assets
Sep 25, 2018
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Aug 24, 2018
Global Tuberculosis (TB) Drugs/Therapeutics Market, 2018-2025 - Key Players are J&J Services, Lupin, Pfizer, Novartis, Macleods Pharmaceuticals, and Otsuka Pharmaceutical
Jul 18, 2018
TB Drugs Market Size Worth $1.38 Billion by 2025 | CAGR: 5.2%: Grand View Research, Inc.
Jul 04, 2018
The global tuberculosis drugs/therapeutics (TB) market size is expected to reach USD 1.38 billion by 2025
Feb 19, 2018
Aeras Highlights Commitment to Eradicating the World's Leading Infectious Disease Killer at the 5th Global Forum on Tuberculosis
Feb 19, 2018
Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Subunit Vaccines
Jan 08, 2018
QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems
Jul 26, 2017
Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
Jun 22, 2017
French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test
Jun 08, 2017
QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval